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ABSTRACT The regulated ability of integrin aIIbb3 to bind ﬁbrinogen plays a crucial role in platelet aggregation and
hemostasis. We have developed a model system based on laser tweezers, enabling us to measure speciﬁc rupture forces
needed to separate single receptor-ligand complexes. First of all, we performed a thorough and statistically representative
analysis of nonspeciﬁc protein-protein binding versus speciﬁc aIIbb3-ﬁbrinogen interactions in combination with experimental
evidence for single-molecule measurements. The rupture force distribution of puriﬁed aIIbb3 and ﬁbrinogen, covalently
attached to underlying surfaces, ranged from ;20 to 150 pN. This distribution could be ﬁt with a sum of an exponential curve for
weak to moderate (20–60 pN) forces, and a Gaussian curve for strong (.60 pN) rupture forces that peaked at 80–90 pN. The
interactions corresponding to these rupture force regimes differed in their susceptibility to aIIbb3 antagonists or Mn21, an aIIbb3
activator. Varying the surface density of ﬁbrinogen changed the total binding probability linearly .3.5-fold but did not affect the
shape of the rupture force distribution, indicating that the measurements represent single-molecule binding. The yield strength
of aIIbb3-ﬁbrinogen interactions was independent of the loading rate (160–16,000 pN/s), whereas their binding probability
markedly correlated with the duration of contact. The aggregate of data provides evidence for complex multi-step binding/
unbinding pathways of aIIbb3 and ﬁbrinogen revealed at the single-molecule level.
INTRODUCTION
The ability of integrins to interact with macromolecular
ligands can be regulated by agonist-induced transmembrane
signaling (1,2). Thus, the integrin aIIbb3 on the surface of
unstimulated platelets has a negligible afﬁnity for soluble
ﬁbrinogen, but readily binds ﬁbrinogen when platelets are
stimulated by agonists such as adenosine diphosphate (ADP)
and thrombin. Although there has been recent progress in
understanding the mechanism of integrin regulation (3), a
number of fundamental issues about ligand binding to in-
tegrins remain to be clariﬁed (4). For example, the location
and even the number of ﬁbrinogen-binding sites on the
aIIbb3 molecule are uncertain (5). Moreover, kinetic studies
suggest that the aIIbb3-ﬁbrinogen interaction is at least
biphasic (6–8), implying that the binding and unbinding
pathways between aIIbb3 and ﬁbrinogen are complex.
The information obtained from conventional receptor-
ligand binding studies that make use of large ensembles of
molecules or whole cells can be substantially enhanced when
the studies are performed at the single-molecule level (9).
This is now possible because of the development of new
biophysical approaches, including atomic force microscopy
(AFM) (10), surface force apparatus (11–13), micropipette
suction technique (14), and the use of hydrodynamic ﬂow
(15). Several of these methods can measure the rupture
forces between individual integrin molecules and their
ligands, including ﬁbrinogen (6,16–19).
We have developed a model system based on laser
tweezers that is suitable for measuring the forces required to
separate single ligand-receptor pairs (rupture forces) using
either puriﬁed proteins or intact living cells. The technique
of optically trapping and manipulating small particles using
a focused laser beam, called laser tweezers, has become a
valuable tool in molecular and cellular biology (20,21).
Because the position of a particle can be determined precisely,
laser tweezers can measure external forces applied to the
particle with extremely high resolution (22,23). Accordingly,
the technique has been used to measure the rigor bond
strength between actin and heavy meromyosin (24,25) or
a-actinin (26), protein A binding to immunoglobulin G (27),
and P- and L-selectins binding to PSGL-1 (28). However,
none of these studies analyzed the stochastic force spectra
produced in many repeated receptor-ligand binding/unbinding
cycles.
We used laser tweezers to study ﬁbrinogen binding to
either puriﬁed aIIbb3 or aIIbb3 on the surface of living
platelets and concluded that there are two states of aIIbb3
activation, inactive and active (29). Nonetheless, further anal-
ysis of the forced unbinding of ﬁbrinogen from aIIbb3
revealed unique features of this receptor-ligand pair. To
increase the credibility and signiﬁcance of the conclusions,
we performed a thorough and statistically representative
analysis of nonspeciﬁc protein-protein binding versus speciﬁc
aIIbb3-ﬁbrinogen interactions in combination with experi-
mental evidence for single-molecule measurements. Here we
provide evidence that yield force histograms of individual
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aIIbb3-ﬁbrinogen interactions display at least two different
components that differ in kinetics, loading rate dependence,
and susceptibility to inhibition or activation. Thus, our data
suggest that although aIIbb3 has only one state capable of
interacting with its ligands, ﬁbrinogen binding to the active
state is a complex multi-step time-dependent process.
METHODS
Principles for measuring bimolecular ﬁbrinogen
binding to aIIbb3 using laser tweezers
We used a model system to study individual ligand-receptor interactions that
permits the measurement of discrete rupture forces produced by surface-
bound ligand-receptor molecular pairs during repeated intermittent contact
(Fig. 1 A). For these studies, puriﬁed aIIbb3 was covalently bound to
stationary pedestals anchored to the inside surface of a ﬂow chamber (Fig.
1 B). Latex beads coated with ﬁbrinogen were then ﬂowed into the chamber.
One of the latex beads was trapped by a laser and moved in an oscillatory
manner so that the bead was intermittently in contact with a stationary
pedestal. The tension produced when ﬁbrinogen on the latex bead interacted
with aIIbb3 on the anchored pedestal caused a deﬂection of the laser beam
that was sensed by a photodetector and displayed as a voltage signal that was
proportional to the strength of ligand-receptor binding (Fig. 1 C). Rupture
forces from interactions between several hundred pedestal-bead pairs were
collected and displayed as normalized force distribution histograms for each
experimental condition. To maximize single integrin-ﬁbrinogen interactions
while decreasing the likelihood of multiple interactions, the integrin and
ﬁbrinogen surface concentrations were deliberately decreased so that the
fraction of contacts resulting in the formation of a speciﬁc bond between
the receptor and the ligand with a yield force .10 pN was ;10% of bead-
pedestal contacts or less. Accordingly, the majority of surface-to-surface
touching events ($90%) resulted in background noise or weak nonspeciﬁc
interactions. The attachment of a ﬁbrinogen-coated bead to an aIIbb3-
coated pedestal could be disrupted by a force of up to 200 pN applied by the
trap.
Optical trap design and calibration
The core of our laser tweezers system is a Nikon (Melville, NY) Diaphot 300
inverted microscope and a 1003 1.3NA Fluor lens combined with a Spectra
Physics (Mountain View, CA) FCBar Nd:YAG laser (l ¼ 1064 nm) with 4
W power in continuous TEM-00 mode (Fig. 2). A computer-operated two-
dimensional acousto-optical deﬂector (Brimrose Corporation of America,
Baltimore, MD) is used to control the tilt of the incoming laser beam at the
back focal plane of the microscope objective, thereby altering the trap
position. Displacement of a bead from the trap center, and consequently the
force exerted by the trap on the displaced bead, are directly proportional
to the beam deﬂection at the back focal plane of the condenser and are
measured with a quadrant detector (30). The output currents from the four
quadrants of the photodiodes are converted to voltages and the four voltages
are combined to yield two voltages proportional to forces in the x and y
directions (Fig. 2). These signals are ﬁltered at 1 kHz and ampliﬁed (Series
902, Frequency Devices Ampliﬁers, Haverhill, MA) and then digitized
at 2000 samples/s using a PC via an analog-to-digital converter board
(catalogue No. PC-MIO-16E-4, National Instruments, Austin, TX). The
voltage signal produced by the photodiode is calibrated in force units using
the power spectrum of Brownian motion (31). Manipulations are recorded
by a video CCD camera. All experiments are conducted at an average trap
stiffness, k ¼ 0.226 0.01 pN/nm (6 SD), as computed from measurements
of the bandwidth of Brownian motion for different beads using the equation:
k ¼ fc3 2pb, where k is the trap stiffness, fc the corner frequency, and b ¼
6phr (h, viscosity; r, bead radius) (31). Force calibration and trap stiffness
are routinely conﬁrmed by the Stokes’ force method (31). LabVIEW
software (National Instruments) is used to control and record laser beam
deﬂection, move the piezoelectric stage (Queensgate Instruments, Berkshire,
UK), and for subsequent off-line data analysis.
FIGURE 1 (A) Schematic drawing of the model
system to study individual receptor-ligand interactions
using laser tweezers. The latex bead coated with ligand
molecules was trapped by the focused laser beam while
moving toward or away from the silica pedestal coated
with polyacrylamide gel-bound receptor molecules,
touching it repeatedly. When the pedestal and the latex
bead bound, the bead position remained nearly
constant as the laser trap continued to move. The force
on the bead increased proportionally to the displace-
ment of the laser focus (DX) from the bead. (B)
Scanning electron microscope image of a 2-mm silica
bead anchored to the bottom of a chamber with
polyacrylamide (upper view). (C) A portion of digi-
tized data showing the force exerted by the trap on the
latex bead during a series of contacts (positive upward
deﬂections) and separations (negative downward
deﬂections).(Point A) In the absence of contact
between the bead and the pedestal the measured force
was small. (Point B) At the moment of contact the laser
trap exerted a positive, compressive force on the
pedestal and the latex bead. The trap motion then
reversed and the compressive force declined to zero.
Peak B represents contact duration time between the
surfaces. (Point C) When the integrin-ﬁbrinogen pair
binds, either speciﬁcally or nonspeciﬁcally, the force
on the bead increased in the negative direction almost
linearly until the pedestal-bead bond was ruptured and the force rapidly returned to nearly zero. (Point D) If no attachment occurred, there was no negative
force. (D) An example of rare jagged signals reﬂecting stepwise unbinding in the case of multiple receptor-ligand interactions.
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Preparation of aIIbb3-coated pedestals and
ﬁbrinogen-coated beads
aIIbb3-coated pedestals were prepared using silica microspheres 1.8–2.0
mm in diameter, as previously described (29). Brieﬂy, a suspension of
microspheres (5% v/v) in 30% (w/v) acrylamide/bis-acrylamide containing
2% (v/v) N,N,N9,N9-tetramethylethylenediamine and 2% (v/v) amyl acetate
was uniformly spread on a clean, dry microscope glass coverslip and air-
dried. Then, a freshly prepared saturated water solution of ammonium
persulfate (2 ml) was smeared uniformly over the surface. A microscopic
chamber (25–50 ml in volume) was assembled, with double-stick tape,
from a glass slide and the polyacrylamide/pedestal-coated coverslip. After
activation of the polyacrylamide-coated surface with glutaraldehyde (10%
v/v, 4 h at room temperature) and thorough washing with the binding buffer
(0.055 M borate buffer, pH 8.5), puriﬁed human aIIbb3 (1 mg/ml) in the
binding buffer with 150 mM NaCl and 1 mM CaCl2 was immobilized for
12–16 h at 4C. The integrity of aIIbb3 heterodimers at alkaline pH and the
lack of substantial oligomerization in the absence of octyl glucoside before
immobilization were conﬁrmed by transmission electron microscopy using
rotary shadowing with tungsten (not shown). After washing to remove
noncovalently adsorbed protein, 2 mg/ml bovine serum albumin (BSA) in
0.055 M borate buffer, pH 8.5, containing 1 mM CaCl2 was added as
a blocker. When Mn21 was used to activate aIIbb, the integrin was pre-
treated with 1 mM Mn21 for 30 min at 37C, and then it was immobilized
in the storage buffer containing the same Mn21 concentration. aIIbb3
antagonists were added to the suspension of ﬁbrinogen-coated beads before
they were introduced into the chamber.
To conﬁrm that the protocol described above resulted in covalent bind-
ing of protein to the polyacrylamide-coated beads, the protocol was used
to attach ﬂuorescein isothiocyanate-conjugated BSA (FITC-BSA) to the
pedestal surface. FITC-BSA (1 mg/ml in binding buffer) was incubated as
described in either a glutaraldehyde-activated chamber or a control untreated
chamber. After thorough washing, the chambers were examined using a
ﬂuorescence microscope. The bottoms of both chambers, as well as the
coated pedestals were highly ﬂuorescent. The chambers were then washed
successively with 20-fold volumes of 4 M urea/1 M NaCl/0.1% SDS and
reexamined. The ﬂuorescence of the glutaraldehyde-activated chamber did
not change, whereas the adsorbed FITC-BSA was washed out of the control
chamber. Further, many pedestals in the untreated chamber detached after
treatment with the chaotropic agents, suggesting that glutaraldehyde, besides
chemical activation of surfaces, cross-linked and anchored the pedestals to
the polyacrylamide-coated coverslip as shown in Fig. 1 B.
For experiments measuring streptavidin binding to biotin, recombinant
streptavidin (Sigma, St. Louis, MO) was adsorbed onto pedestals whose
surface was covalently coated with biotin-BSA to spatially orient the
streptavidin molecules. Biotin-coated latex microspheres 1 mm in diameter
were purchased from Sigma. Preincubation of a streptavidin-containing
chamber with free biotin almost completely abrogated bead attachment,
conﬁrming the speciﬁcity of the streptavidin-biotin binding measured by the
laser tweezers.
Human ﬁbrinogen was covalently bound to 0.93 mm carboxylate-
modiﬁed latex beads (Bangs Laboratories, Fishers, IN) using
N-(3-dimethylaminopropyl)-N9-ethylcarbodiimide hydrochloride as a cross-
linking agent in a two-step procedure. After activation in 0.1 M 2-
(N-morpholino)ethanesulphonic acid, pH 5.2, by mixing 1 ml of the buffer,
10 ml of a 10% bead suspension, 1.5 mg of dry carbodiimide, followed
by constant shaking for 15 min at 4C, the beads were sedimented, washed
once with binding buffer (0.055 M borate buffer, pH 8.5), resedimented, and
suspended in 20 mg/ml ﬁbrinogen solution in binding buffer. After 15 min
incubation with stirring at 4C, the beads were sedimented and resuspended
in BSA solution (2 mg/ml in 0.055 M borate buffer, pH 8.5) or 1 M
ethanolamine solution in the same buffer. Fibrinogen-coated beads were
freshly prepared and mildly sonicated to disrupt aggregates before each
experiment.
The density of 125I-ﬁbrinogen on the surface of carbodiimide-activated
beads depended on the concentration of ﬁbrinogen in the binding solution
(Fig. 3). The surface density of ﬁbrinogen ranged from 2 3 109 to 11 3
109 mg/mm2 or from 3.73 103 to 2.03 104 molecules/1mm2 (13 104–5.5
3 104 molecules/bead) with a saturation achieved at a ﬁbrinogen con-
centration of ;30 mg/ml.
aIIbb3 heterodimers were isolated from detergent extracts of human
platelets by afﬁnity chromatography (32) and ﬁbrinogen was purchased
from American Diagnostica (Stamford, CT). The polypeptide composition,
purity, and lack of oligomerization of aIIbb3 and ﬁbrinogen were assessed
by SDS-polyacrylamide gel electrophoresis and by transmission electron
microscopy using rotary shadowing with tungsten (33,34). Functionality of
the aIIbb3 preparations was conﬁrmed by ability of the integrin to bind
ﬁbrinogen in solution and its susceptibility to activating effects of
FIGURE 2 Optical scheme of the laser tweezers setup. The optical trap is
generated with a 4-W Nd:YAG laser (l ¼ 1064 nm, Spectra Physics). A
two-dimensional acousto-optical deﬂector (Brimrose Corporation of Amer-
ica) enables rapid (;3 ms) electronic control of the trap position. Bead forces
are measured with a ‘‘back focal plane’’ force detector (71,72). The
detectors are quadrant photodiodes (Current Designs, Philadelphia, PA)
placed at a plane optically conjugate to the back focal plane of the condenser.
The intensity distribution at the quadrant detectors indicates the deﬂection of
the bead relative to the center of the trap, which is proportional to the applied
force.
FIGURE 3 Number of ﬁbrinogen molecules bound to each carbodiimide-
activated carboxylate-modiﬁed bead as a function of initial ﬁbrinogen con-
centration in the binding reaction mixture.
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dithiothreitol and manganese ions (35). Fibrinogen was 95–97% clottable
with thrombin, which conﬁrms the high purity and activity of the protein.
Experimental procedure
To study the interaction between ﬁbrinogen and puriﬁed aIIbb3, 1 ml of
a suspension of ﬁbrinogen-coated beads (107 beads/ml) was added to 50 ml
of 0.1 M HEPES buffer, pH 7.4, containing 2 mg/ml BSA, 0.1% Triton
X-100, and 1 mM CaCl2 (or MnCl2). The mixture was introduced into
a chamber containing aIIbb3-coated pedestals. The experiments were per-
formed in the presence of BSA and Triton X-100 to reduce the non-
speciﬁc interactions. After the chamber was placed on a microscope stage,
a single bead was trapped by the laser beam. Using a manual stage, an
aIIbb3-coated pedestal was brought to within 1–2 mm of the trapped bead
and the microscope focus was adjusted so that the bead and pedestal centers
were the same distance from the coverslip surface (Fig. 1 A). The position of
the laser trap was then oscillated in a triangular waveform with frequencies
of 0.5 Hz, 5 Hz, or 50 Hz and a constant peak-to-peak amplitude of 800 nm.
The distance separating the pedestal and the bead was reduced in 10-nm
steps using the piezostage until repeated contacts were observed (Fig. 1 C).
The piezostage position was adjusted so that the peak compressive force was
10–30 pN (Fig. 1C, peak B) or the duration of contact was 2–5 ms at a 50-Hz
oscillation frequency. When ﬁbrinogen was bound to aIIbb3, the bead
stopped moving and a linear increase in force (loading rate) was observed
(Fig. 1 C, peak C). If force ramps were not observed within 30 s, the bead
was moved to a new pedestal surface. The integrin and ﬁbrinogen surface
concentrations were adjusted so that one in two pedestals produced de-
tectable bonds. The loading rate depends on the trap stiffness and speed of
separation of the pedestal and bead. Rupture forces were measured at the
pulling speeds of 800, 8000, and 80,000 nm/s, corresponding to the three
oscillation frequencies. With a 0.2-pN/nm trap stiffness, these are equivalent
to loading rates of 160, 1600, and 16,000 pN/s, respectively. The loading
rate for all experiments was 16,000 pN/s unless otherwise indicated. Data
recording was initiated at ﬁrst contact and was digitized at the rate of 2000
samples/s.
Data processing and analysis
The response time for the motion of a trapped bead that is not bound to
a pedestal is ,50 ms at the trap stiffness used. The bond ruptures were
therefore observed as abrupt discrete decreases of trap force occurring within
one sampling period (Fig. 1 C). The largest step decrease of force measured
at times separated by two sample intervals during each period that the trap
was moving away from the pedestal was counted as a rupture force. In the
absence of bead-pedestal contacts and therefore of bond ruptures, the largest
force transients were in the range of 0–10 pN and were due to Brownian
noise. Data was recorded and analyzed with custom LabVIEW (National
Instruments) programs.
The number of contacts recorded for each pedestal and bead pair
depended on the oscillation frequency and was on average ;2000 contacts
at 50 Hz, 850 contacts at 5 Hz, and 90 contacts at 0.5 Hz. For each bead
pedestal pair the sequence of rupture forces were sorted into a histogram
with 10-pN-wide bins and normalized by total number of contacts. The
percentage of events in a particular force range (bin) represents the prob-
ability of a bond rupture in that force range. The ﬁrst bin in the histograms,
forces in the range of 0–10 pN, represented noise or optical artifacts in
combination with weak nonspeciﬁc interactions. Accordingly, the ﬁrst bin
was neglected in data presentation and analysis. The results of experiments
for multiple (;50) bead-pedestal pairs under similar conditions were aver-
aged so that each probability histogram shown and/or analyzed in the Results
section represented several thousand to ;105 contacts between similar
reacting surfaces. Each point of a probability histogram was calculated as an
average 6 SD from individual ﬁles collected from separate pedestal-bead
pairs.
RESULTS
Rupture force distribution of the speciﬁc
aIIbb3-ﬁbrinogen binding versus nonspeciﬁc
protein-protein interactions
The distribution of rupture forces between aIIbb3- and
ﬁbrinogen-coated surfaces ranged from several piconewtons
to 150 pN, with the probability of forces .130 pN being
,0.01% (Fig. 4, curve 1). A typical histogram of yield forces
omitting the 0–10 pN point contained two regimes of
moderate and strong binding, corresponding to ;20–60 pN
and 60–130 pN, respectively (Fig. 4).
The two components of the yield force histogram were
then modeled with an empirically determined function as the
sum of an exponential and a Gaussian curve, as described by
Eq. 1:
Y ¼ a13 expðx=b1Þ1 a23 expðððx  cÞ=b2Þ2Þ: (1)
This two-component ﬁt was used to quantify the force
distributions and to compare aIIbb3-ﬁbrinogen interactions
registered under different experimental conditions (see
Tables 2–4). The rupture forces in the range 20–60 pN
were typically well ﬁt with an exponential and stronger yield
forces in the range 60–130 pN were well ﬁt with a Gaussian
curve centered at;80–90 pN. The ﬁt parameter b1 gives the
FIGURE 4 Yield force distribution of forces required to rupture in-
teractions between integrin aIIbb3- and ﬁbrinogen-coated beads (curve 1)
compared to nonspeciﬁc interactions (curves 2–5). The rupture force
distribution of the integrin-ﬁbrinogen interactions is ﬁtted with a sum of an
exponential and a Gaussian function. The number of ruptures .10 pN used
to plot curve 1 is 19,788 (19.8% of the total number of contacts, n¼ 99,938).
The zero point (0–10 pN bin), which represented the remaining 80.2%, is
omitted. The different force regimes are marked with the backgrounds of
various intensities. The probability of moderate or strong force interac-
tions is higher for integrin-ﬁbrinogen than for nonspeciﬁcally interacting
protein-coated surfaces: (curve 2) BSA-coated beads with untreated poly-
acrylamide-coated pedestals (2.8% ruptures .10 pN, n ¼ 9,988); (curve 3)
ﬁbrinogen-coated beads with BSA-coated pedestals (0.9%, n ¼ 16,885);
(curve 4) BSA-coated beads with integrin aIIbb3-coated pedestals (3.6%,
n ¼ 35,334); and (curve 5) ﬁbrinogen-coated beads with EDTA-pretreated
integrin aIIbb3 bound to pedestals (7.6%, n ¼ 14,134). The points in curve
1 represent averages from individual pedestal-bead pairs 6 SD.
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average and c gives the most probable rupture forces for the
moderate and strong interactions, respectively.
To distinguish between speciﬁc and nonspeciﬁc binding
(36), two types of control experiments were performed. In
the ﬁrst type, one or both ligand and receptor molecules were
omitted or substituted with noninteracting proteins (Fig. 4,
curves 2–5). In the second, inhibitors speciﬁc to aIIbb3 were
used to reduce or eliminate speciﬁc interactions (Table 1).
The majority of rupture forces were ,20 pN for all the
surface treatments (Fig. 4) and inhibitors (Table 1). For the
aIIbb3-ﬁbrinogen interactions, ruptures .20 pN accounted
for;15% of the interactions whereas for the control surfaces
the probability for observing ruptures .20 pN was in the
range 0.08–1.0% (Fig. 4). The weakest interactions, with all
ruptures occurring at forces ,30 pN, were observed for
untreated polyacrylamide-coated pedestals in contact with
BSA-coated beads (Fig. 4, curve 2). Pedestal surfaces were
slightly more reactive with BSA-coupled beads after cova-
lent coupling with ﬁbrinogen (Fig. 4, curve 3) or with in-
tact aIIbb3 (Fig. 4, curve 4). The most effective inhibitor
was pretreatment of the aIIbb3 with EDTA (1 mM) before
and during the immobilization of aIIbb3 to the pedestals.
EDTA causes dissociation of aIIbb3 into its two subunits,
thereby destroying speciﬁc ﬁbrinogen-binding sites (34,37).
The probability for rupture forces .20 pN during the
interaction of EDTA-treated aIIbb3 molecules with ﬁbrin-
ogen was higher than any of the surface controls but still
.15-fold lower than for intact aIIbb3- and ﬁbrinogen-
coated surfaces (Fig. 4, curve 5). These data suggest that
nearly all of the nonspeciﬁc interactions are limited to rup-
tures (at 16,000 pN/s loading rate) occurring at ,20 pN,
.90% of the ruptures in the range 20–60 pN are likely
speciﬁc interactions, and virtually all of the ruptures occur-
ring at.60 pN are speciﬁc. Accordingly, the remaining anal-
ysis will focus exclusively on ruptures at forces .20 pN.
Discriminating single versus multiple
aIIbb3-ﬁbrinogen bonds
Several criteria were used to test whether the observed
ruptures were due to single or multiple bonds (29,38). First,
the rupture of interactions due to multiple bonds should oc-
cur in a sequence of multiple steps, whereas the rupture due
to single bonds should always occur in a single step. Typically
99.8–99.9% of the ruptures occurred in one step (as in Fig. 1
C) and 0.1–0.2% occurred in two or more steps separated by
.0.5 ms (as in Fig. 1 D). The bond ruptures that occurred in
multiple steps were not included in the histograms.
Second, the histograms of the distribution of rupture forces
of multiple identical interactions should appear as a series of
quantized peaks that are multiples of a single value of force
and have probabilities inversely proportional to the number of
bonds. For the strong interactions we observed only a single
well-deﬁned peak in the force histograms (Fig. 4, curve 1).
Third, the yield strength for single bonds should be
independent of the surface density of either the receptor or
ligand (39). The surface density of ﬁbrinogen molecules was
changed over the range 3.7 3 103–2.0 3 104 molecules/
1 mm2 by changing its initial concentration from 3.4 to 640
mg/ml in the binding solution added to the activated latex
beads (Fig. 3). The highest value is comparable with the satu-
rating surface density of ﬁbrinogen reported by others (40).
Rupture forces between surface-bound ﬁbrinogen andaIIbb3
molecules were measured using beads prepared under
identical conditions with three substantially different ﬁbrin-
ogen surface densities. To control for the variability of the
integrin preparation, the three bead preparations synthesized
were ﬂowed, in succession, through a chamber containing
aIIbb3-coated pedestals and rupture force distributions were
measured (Table 2). The rupture forces for both the moderate
and strong force ranges remained unchanged. The average
cumulative probability for binding events with rupture forces
.20 pN varied from 0.6% to 2.7% (Table 2) and the pro-
babilities depended linearly on ﬁbrinogen surface density for
both the moderate and the strong interaction regimes of the
yield forces (Fig. 5). Thus, variations in surface density of
ﬁbrinogen correlate directly with changes in the probability of
ﬁbrinogen-integrin binding but they have no effect on the
yield strength.
TABLE 1 Effect of speciﬁc aIIbb3 antagonists on the




of contactsInhibitors 20–60 pN .60 pN
H12-peptide (1 mM) 123 0.6% 348 1.7% 20,486
Without the inhibitor 506 2.9% 940 5.4% 17,439
Tiroﬁban (50 mM) 113 0.4% 308 1.2% 25,741
Without the inhibitor 468 2.1% 763 3.4% 22,290
RGDS peptide (1 mM) 155 0.8% 308 1.5% 20,037
Without the inhibitor 524 2.8% 703 3.8% 18,297
mAb A2A9 (100 mg/ml) 148 0.9% 108 0.6% 17,074
Without the inhibitor 333 2.2% 511 3.3% 15,336
abciximab (100 mg/ml) 268 1.0% 174 0.7% 25,371
Without the inhibitor 377 1.9% 497 2.4% 20,298
Noninhibitory mAb SSA6
(100 mg/ml)
160 1.2% 203 1.5% 13,412
Without mAb SSA6 298 1.6% 368 1.9% 18,937
Values in Table 1 are presented as number of events and percentage of total
number of contacts.
TABLE 2 Yield strength and probability of the aIIbb3-
ﬁbrinogen interactions with different ﬁbrinogen surface density
Fibrinogen surface
density, mg/mm2
Yield strength, pN Cumulative probability (%)
20–60 pN .60 pN 20–60 pN .60 pN
2 3 109 32.6 6 1.1 79.1 6 1.5 0.32 6 0.09 0.19 6 0.04
7 3 109 30.6 6 1.6 76.4 6 1.8 0.86 6 0.16* 0.57 6 0.08y
11 3 109 32.8 6 1.4 76.9 6 1.2 1.59 6 0.35* 1.04 6 0.27y
*,yp , 0.01.
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These data suggest that the surface density of receptor and
ligand are low enough so that at most one integrin-ﬁbrinogen
bond is formed during each contact.
The moderate and strong force regimes respond
differently to inhibition and enhancement of the
aIIbb3-ﬁbrinogen interactions
Our previous qualitative comparisons of yield force dis-
tributions between ﬁbrinogen and aIIbb3 suggested that the
moderate and strong rupture forces resulted from speciﬁc
ﬁbrinogen binding to aIIbb3, whereas the weak forces were
nonspeciﬁc (29). However, further study of the moderate and
strong yield force regimes have revealed a number of dif-
ferences in addition to the magnitude of the rupture force
required to disrupt ﬁbrinogen binding to aIIbb3. First, small-
molecule aIIbb3 antagonists such as the ﬁbrinogen g chain
peptide H12 peptide, the peptidomimetic tiroﬁban, and the
tetrapeptide Arg-Gly-Asp-Ser (RGDS) were most effective
in inhibiting moderate force interactions, whereas the inhi-
bitory monoclonal antibodies A2A9 and abciximab were
substantially more effective in inhibiting strong interactions
(Fig. 6). Second, whereas preincubation of the ﬁbrinogen-
coated latex beads with soluble aIIbb3 molecule abrogated
stronger aIIbb3-ﬁbrinogen interactions, they augmented
rupture forces in the moderate range, perhaps as a conse-
quence of aIIbb3-aIIbb3 binding (1) (not shown). Third, the
relative probability of detecting moderate and strong rupture
forces was affected by the length of time the aIIbb3
preparation had been stored at 4C (Fig. 7). We found that
the most labile component of the aIIbb3-ﬁbrinogen inter-
action was the strong force regime, which decreased as a
function of the time of storage, whereas there was no cor-
responding change in the moderate force regime. Fourth, we
found that Mn21, a divalent cation which induces a confor-
mational change in the extracellular domain aIIbb3 that
increases its afﬁnity for ﬁbrinogen (35), enhanced the strong
component of the yield force distribution .2.5-fold, but
increased the moderate component only 1.5-fold (p , 0.01)
(Fig. 8). However, the aIIbb3 antagonists, tiroﬁban and
abciximab, both effectively abrogated both types of binding
FIGURE 5 The probability of observing moderate (20–60 pN) and strong
(.60 pN) binding forces between integrin aIIbb3 and ﬁbrinogen as
functions of the ﬁbrinogen surface density. The number of ruptures.20 pN
included in the analysis were 258 (0.6%; number of contacts, n ¼ 42,998)
for ﬁbrinogen surface density of 23 109 mg/mm2, 541 (1.5%, n ¼ 36,072)
for 7 3 109 mg/mm2, and 862 (2.7%, n ¼ 31,921) for 113 109 mg/mm2.
The results are shown as an average from individual pedestal-bead pairs6 SD.
FIGURE 6 Effect of integrin aIIbb3 antagonists on aIIbb3-ﬁbrinogen
binding. The relative probability for forming bonds with rupture forces in the
weaker (20–60 pN) and stronger (.60 pN) rupture force regimes for integrin
aIIbb3 treated with 1 mM H12-peptide (ﬁbrinogen-binding inhibitor
dodecapeptide) (n ¼ 30,473), 40 mM tiroﬁban (n ¼ 61,056), 1 mM
RGDS (n ¼ 88,178), 100 mg/ml aIIbb3-binding speciﬁc ‘‘antiaggregant’’
monoclonal antibodies A2A9 (n ¼ 46,353), 100 mg/ml abciximab (n ¼
32,469), and 100 mg/ml noninhibitory aIIbb3-speciﬁc mAb SSA6 (n ¼
13,412) normalized to untreated aIIbb3 (*p , 103 for comparative
inhibitory efﬁcacy in the lower and higher force regimes). Positive control
data with untreated aIIbb3 were collected for each of the inhibitors in the
same chamber before addition of an inhibitor and were statistically com-
parable by the number of contacts (Table 2). The results are shown as an
average from individual pedestal-bead pairs 6 SD.
FIGURE 7 Effect of storage of the integrin aIIbb3 preparation at 4C on
the yield force distribution of the integrin aIIbb3-ﬁbrinogen interactions
(data from an individual experiment with 31,936 contacts for fresh integrin
and 37,174 for the same integrin preparation after 8 days of storage).
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forces in the presence and absence ofMn21 suggesting that they
represent speciﬁc aIIbb3-ﬁbrinogen binding and unbinding.
Dependence of the yield force on loading rates
and contact duration
Changes in the yield force distribution with loading rate can
be used to estimate the energy landscape and kinetic pa-
rameters for a particular receptor-ligand pair (41–45). To
change both the loading rate and contact duration in our
experiments, we varied the oscillation frequency.
Since the loading rate dependence of rupture forces was
ﬁrst demonstrated for streptavidin-biotin interactions (45),
we used this receptor-ligand pair to validate our experimental
protocol and subsequent analysis. The effect of loading rate
on the rupture force distributions for biotin-streptavidin
interactions is shown in Fig. 9. The most probable rupture
force (yield strength) of the strong force distribution was
linearly dependent on the log of the loading rate and in-
creased 2.5-fold when the loading rate changed from 23 to
11,500 pN/s. The transition state distance or location of the
activation barrier calculated from the slope (42) was found to
be ;0.5 nm, in good agreement with previous data obtained
using a biomembrane force probe (45). Increasing the
loading rate to 23,000 pN/s resulted in a further shift of the
rupture forces such that the laser trap was most often unable
to separate bound molecules.
Similar experiments examining ﬁbrinogen binding to
aIIbb3 produced very different results (Fig. 10). The yield
strength for the strong force component of ﬁbrinogen bind-
ing to aIIbb3 was independent of loading rates in the range
of 160–16,000 pN/s (Table 3). On the other hand, the
cumulative probability of strong ﬁbrinogen-aIIbb3 inter-
actions was inversely proportional to the oscillation fre-
quency and directly proportional to the duration of contact,
reaching almost 9% at the lowest loading rate and the
greatest contact duration studied. Surprisingly, the average
rupture force for the moderate force regime decreased at
higher oscillation frequencies. As expected, the cumulative
probability for the moderate force component decreased at
higher oscillation frequencies and increased with increasing
contact duration (Table 4).
FIGURE 8 Effect of Mn21 on the ﬁbrinogen binding activity of integrin
aIIbb3 in the absence and presence of 50 mM tiroﬁban and 100 mg/ml
abciximab in the lower (20–60 pN) and higher (.60 pN) yield force
regimes. The data were collected at 5-Hz bead oscillation frequency using
12–50 different pedestal-bead pairs for each experimental condition. There
were 1,663 ruptures.20 pN used to plot the bar graphs for control aIIbb3-
ﬁbrinogen interactions without Mn21 (5.9% of total contacts, n ¼ 28,203)
and 4,587 ruptures (10% of contacts, n¼ 45,871) used to plot bar graphs for
interactions with Mn21. In the presence of Mn21 and tiroﬁban the number of
.20-pN ruptures was 201 (0.94%, n ¼ 21,383); in the presence of Mn21
and abciximab they were 164 (1.7%, n ¼ 9,647). Each point is calculated as
an average from individual pedestal-bead pairs 6 SD.
FIGURE 9 Dependence of the yield strength of streptavidin-biotin
interactions on the loading rate. The number of forces .20 pN included
in the analysis were 74 (14%, n ¼ 528) for the loading rate of 23 pN/s (0.1-
Hz bead oscillation frequency), 82 (4%, n¼ 2,057) for 230 pN/s (1 Hz), 792
(6%, n ¼ 13,196) for 2,300 pN/s (10 Hz), and 1,091 (5%, n ¼ 21,825) for
11,500 pN/s (50 Hz). Each point is calculated as an average from individual
pedestal-bead pairs 6 SD.
FIGURE 10 Rupture force distribution of the integrin aIIbb3-ﬁbrinogen
interactions at different loading rates. The data were collected during
repeated touching of the same surfaces (19 pedestal-bead pairs) at different
bead oscillation frequency. The total number of contacts included in the
histograms was 1,784 for 160 pN/s (0.5 Hz), 13,311 for 1,600 pN/s (5 Hz),
and 51,535 for 16,000 pN/s (50 Hz). Each point is calculated as an average
from individual pedestal-bead pairs 6 SD.
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Because there was variation in contact duration at the
same oscillation frequency, the interaction probabilities versus
contact duration were analyzed in more detail. We found that
the dependence of interaction probability on contact duration
differed for each component of the rupture force histogram
(Fig. 11). Thus, the probability of detecting weaker binding
interactions is greater than for stronger interactions during
brief contacts, suggesting that the weaker interactions form
faster.
DISCUSSION
Using laser tweezers-based force spectroscopy, we studied
the rupture force proﬁle of bimolecular aIIbb3-ﬁbrinogen
interactions, which appeared as a complex bimodal force
distribution with at least two regimes, namely 20–60 pN and
.60 pN. The rupture force regimes turned out to be sub-
stantially different in a number of important characteristics,
implying that they reﬂected interactions of different origin.
Based on several criteria that have been proposed to test
whether the observed ruptures were due to single or multiple
bonds (29,38), our data strongly indicate that under the ex-
perimental conditions studied the rupture events were due
to single bonds. First, the rupture of bonds occurred in a sin-
gle step in .99% of force counts. Second, the histograms
of the distribution of rupture forces did not appear as a series
of peaks, as would be predicted if the identical interactions
were multiple. Third, the binding strength was constant at in-
creased surface densities of the interacting proteins, showing
that only one aIIbb3-ﬁbrinogen pair was involved irrespective
of the number of molecules present on the surfaces (Table 2).
Fourth, the probability of both moderate and strong inter-
actions increased linearly with the density of molecules on the
surfaces (Fig. 5), consistent with single-molecule binding.
To ensure that the majority of the rupture events were due
to single bonds, the experimental conditions were tuned to
keep the frequency of binding between aIIbb3-coated
pedestals and ﬁbrinogen-coated beads low, speciﬁcally so
that only 1–10% of total interface contacts resulted in
interactions with ruptures .20 pN. To accumulate a statis-
tically signiﬁcant number of events and compensate for these
low probabilities, a very large number of contacts was re-
quired. The ability to collect data with large numbers of
contacts is one of the main advantages of the rupture force
assay based on an oscillating optical trap.
The force limit of our measurement system, as determined
by thermal ﬂuctuations of the trapped bead, is ;10 pN.
Therefore, only those bonds that rupture at forces in the
range 10–200 pN are detectable. Careful control experiments
(Fig. 4, curves 2–5) show that the large majority of the
nonspeciﬁc interactions occur with rupture forces ,20 pN.
Accordingly, we focused our attention on the yield forces in
the range 20–200 pN, which was segregated into moderate
(20–60 pN) and strong (.60 pN) force regimes. The mod-
erate and strong rupture force regimes both resulted from
ﬁbrinogen bound to aIIbb3, but were different in a number
of important characteristics. The kinetic behavior for the two
force regimes was different, with the weaker interactions
forming faster than the stronger ones, suggesting a complex
pathway for aIIbb3 and ﬁbrinogen interactions that could
result from either multiple receptor-ligand binding/unbind-
ing steps or from intermediate integrin receptor activation
states. Consistent with the former possibility, we found that
the moderate force interactions were more effectively inhib-
ited by small-molecule antagonists, whereas the strong
interactions were more effectively inhibited by substantially
larger anti-aIIbb3 monoclonal antibodies. Moreover, the
stronger forces were more labile during storage and were
more sensitive to the perturbing effect of Mn21 on the
TABLE 3 Yield strength and cumulative probability of the
strong ([60 pN) aIIbb3-ﬁbrinogen interactions at different









160 0.320 6 0.118 82.9 6 1.5 8.6 6 2.5
1,600 0.030 6 0.009 80.1 6 2.1 1.9 6 0.5
16,000 0.004 6 0.001 83.2 6 2.9 0.5 6 0.2
TABLE 4 Yield strength and cumulative probability of the
moderate (20–60 pN) aIIbb3-ﬁbrinogen interactions at









160 0.320 6 0.118 43.1 6 4.6 2.00 6 0.42
1,600 0.030 6 0.009 35.6 6 3.2 0.58 6 0.18
16,000 0.004 6 0.001 31.5 6 2.1 0.27 6 0.07
FIGURE 11 Probability for observing low (20–40 pN), moderate (40–60
pN), and strong (.60 pN) binding forces between integrin aIIbb3 and ﬁbrino-
gen depends on duration of contact between bead and pedestal. The contact
time needed to reach half-maximal ﬁbrinogen binding at a constant loading
rate of 1,600 pN/s was1 ms for the 20–40 pN, 20 ms for the 40–60 pN, and
70 ms for the .60 pN force regimes. Errors of cumulative probability
(Y-scale) and contact duration (X-scale) were calculated as standard deviations.
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conformation of the aIIbb3 extracellular domain (35). Taken
together, these data suggest a model for ﬁbrinogen binding
to aIIbb3 in which their initial interaction is followed by
reorganization of the binding interface, thereby enhancing
the strength of binding (Fig. 12).
Consistent with this, it has been reported that puriﬁed
aIIbb3 binds to ﬁbrinogen in a time-dependent two-step
process. Thus, after rapidly reaching an initial reversible
bound state, the aIIbb3-ﬁbrinogen complex becomes more
stable (8) and dissociates only in the presence of high con-
centrations of the tetrapeptide Arg-Gly-Asp-Val, or RGDV
(7). Time dependence is also observed when a load is imposed
on the interaction. For example, Goldsmith et al. (6) found that
the shear-induced breakup of aIIbb3-coated latex spheres
cross-linked by ﬁbrinogen depended on the time of contact
between the spheres, suggesting the existence of ‘‘young’’
weak versus ‘‘old’’ strong aIIbb3-ﬁbrinogen interactions.
An alternative explanation for our data, illustrated in Fig.
13, is based on the assumption that aIIbb3 exists in a number
of activation states having different ligand-binding afﬁnities.
This alternative posits that the various ligand-binding af-
ﬁnities depend on the nature and/or amount of integrin-
activating stimuli (46–52). Although our data are not, by
themselves, sufﬁcient to differentiate between these models,
there are a number of arguments that favor ‘‘multiple binding
steps’’ over ‘‘multiple activation states’’. First, structural
studies of aIIbb3 and another integrins performed using
transmission electron microscopy and x-ray crystallography
revealed either open or closed molecular conformations
without intermediate forms (35,53). Second, platelet stimu-
lation, using ADP or the thrombin receptor activating
peptide, TRAP, enhances the accessibility, but not the
adhesion strength of single aIIbb3 molecules, consistent
with the presence of only two aIIbb3 activation states (29).
Third, analysis of rupture force spectra obtained for aIIbb3
and ﬁbrinogen in ADP-stimulated platelets (29) did not
reveal changes in the moderate force regime as the ADP con-
centration increased, indicating that ﬁbrinogen-binding afﬁnity
of individual aIIbb3 molecules is either on or off, regardless
of the strength of the platelet stimulus.
It should be mentioned that the moderate force regime
might reﬂect partially denatured protein molecules rather
than an intermediate receptor binding step or activation state.
The data presented in this work are not, by themselves,
sufﬁcient to exclude this artifact; however, the moderate
force regime was observed not only with puriﬁed proteins
but also in live platelets where the integrin is secured from
denaturing (29,38). As to ﬁbrinogen, its functional homoge-
neity on the surface of latex beads was demonstrated in
binding experiments with ﬁbrin and its fragments (R. Litvinov,
O. Gorkun, S. Owen, H. Shuman, and J. Weisel, unpublished
data), with uniform and strong rupture forces showing up as
one sharp peak without any intermediate force regime.
Dynamic force spectroscopy has been used to extract the
thermodynamic and kinetic characteristics of speciﬁc inter-
molecular interactions underlying receptor-ligand binding.
In most cases, the average rupture force, or yield strength,
increased with loading rate and displayed mono- or multi-
phasic logarithmic dependence over a wide range of loading
rates (17,19,54–59). However, the loading rate dependence
for aIIbb3-ﬁbrinogen unbinding did not follow this trend.
The yield strength for the strong force regime was ;82 pN,
independent of loading rates .3 orders of magnitude. The
constant yield strength likely reﬂects intrinsic properties of
aIIbb3 because control experiments with biotin-streptavidin
reproduced earlier measurements using other techniques
(45). A constant yield strength implies that the transition
state distance is large (43) and has been observed for several
other receptor-ligand pairs (60–62). The yield strength for
the moderate force regime (Fig. 10, Table 2) decreased at
higher loading rates. Although an inverse relationship
between rupture force and loading rate is counterintuitive,
it has also been observed in other systems (63,64) and may
reﬂect a failure of the simplest model for unbinding (65–68).
It was noted earlier that the probability of integrin-
ﬁbrinogen binding changes inversely with oscillation fre-
quency and is attributable to changes in contact duration, as
was demonstrated earlier for the interactions between ﬁbro-
nectin and bacterial adhesion molecules (69). Accordingly,
the decreasing yield strength of the moderate force inter-
actions may be due to changes in contact duration between
the bead and pedestal at different oscillation frequencies.
For example, as shown in Fig. 11, the moderate interactions
(20–60 pN) may have two components: rapid interactions
at 20–40 pN and slower interactions at 40–60 pN so that at
high oscillation frequency (short contact duration), the lowest
force interactions predominate. However, because loading
rate and contact duration change with oscillation frequency,
it is not at present possible to discriminate between these two
possibilities.
FIGURE 12 Schematic presentation of multiple receptor-ligand binding/
unbinding steps.
FIGURE 13 Schematic presentation of multiple receptor activation states.
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In conclusion, our data suggest that ﬁbrinogen binding to
aIIbb3 is a complex, time-dependent, multi-step process,
during which the strength of the bond between aIIbb3 and
ﬁbrinogen appears to progressively increase. This may be
of physiological importance because ﬁbrinogen binding to
aIIbb3 occurs in an environment where contact duration
is determined by shear. Moreover, it may account for von
Willebrand factor-mediated slowing of platelet velocity
required to establish a stable aIIbb3-mediated platelet
thrombus (70).
This work was supported by grants HL57407, HL30954, HL40387, and
HL62250 from the National Institutes of Health.
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